References
- Buisson P, Leclair MD, Jacquemont S, Podevin G, Camby C, David A, et al. Cutaneous lipoma in children: 5 cases with Bannayan-Riley-Ruvalcaba syndrome. J Pediatr Surg 2006;41:1601-3. https://doi.org/10.1016/j.jpedsurg.2006.05.013
- Schreibman IR, Baker M, Amos C, McGarrity TJ. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005;100:476-90. https://doi.org/10.1111/j.1572-0241.2005.40237.x
- Bannayan GA. Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome. Arch Pathol 1971;92:1-5.
- Genetics Home Reference. Bannayan-Riley-Ruvalcaba syndrome [Internet]. Bethesda: U. S. National Library of Medicine; 2012 [cited 2016 Mar 13]. Available from: https://ghr.nlm.nih.gov/condition/bannayan-rileyruvalcaba-syndrome.
- Genetics Home Reference. Cowden syndrome [Internet]. Bethesda: U. S. National Library of Medicine; 2012 [cited 2016 Mar 13]. Available from: https://ghr.nlm.nih.gov/condition/cowden-syndrome.
- Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet 2008;16:1289-300. https://doi.org/10.1038/ejhg.2008.162
- Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998;7:507-15. https://doi.org/10.1093/hmg/7.3.507
- Parisi MA, Dinulos MB, Leppig KA, Sybert VP, Eng C, Hudgins L. The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. J Med Genet 2001;38:52-8. https://doi.org/10.1136/jmg.38.1.52
- Latiff ZA, Atmawidjaja RW, RajaLope RJ, Syed Omar SA, Syed Zakaria SZ, Jamal RA. Bannayan Riley Ruvalcaba syndrome. Ann Acad Med Singap 2010;39:578-82.
- Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 2007;44:579-85. https://doi.org/10.1136/jmg.2007.049981
- Hobert JA, Eng C. PTEN hamartoma tumor syndrome: an overview. Genet Med 2009;11:687-94. https://doi.org/10.1097/GIM.0b013e3181ac9aea
- Gontijo GM, Pinto CA, Rogatto SR, Cunha IW, Aguiar S Jr, Alves CA. Bannayan-Riley-Ruvalcaba syndrome with deforming lipomatous hamartomas in infant--case report. An Bras Dermatol 2013;88:982-5. https://doi.org/10.1590/abd1806-4841.20132730
- Zhou XP, Waite KA, Pilarski R, Hampel H, Fernandez MJ, Bos C, et al. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 2003;73:404-11. https://doi.org/10.1086/377109
- Eng C. PTEN hamartoma tumor syndrome (PHTS) [Internet]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews. Seattle: University of Washington; 2001 Nov 29 [updated 2014 Jan 23; cited 2016 Mar 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1488/.
- Shaffer LG, Bejjani BA. Using microarray-based molecular cytogenetic methods to identify chromosome abnormalities. Pediatr Ann 2009;38:440-7. https://doi.org/10.3928/00904481-20090723-08
- Menko FH, Kneepkens CM, de Leeuw N, Peeters EA, Van Maldergem L, Kamsteeg EJ, et al. Variable phenotypes associated with 10q23 microdeletions involving the PTEN and BMPR1A genes. Clin Genet 2008;74:145-54. https://doi.org/10.1111/j.1399-0004.2008.01026.x
- Seo EJ. Clinical applications of chromosomal microarray analysis. J Genet Med 2010;7:111-8. https://doi.org/10.5734/JGM.2010.7.2.111
- Manning M, Hudgins L; Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010;12:742-5. https://doi.org/10.1097/GIM.0b013e3181f8baad
- Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-64. https://doi.org/10.1016/j.ajhg.2010.04.006
Cited by
- The Rare Neurocutaneous Disorders: Update on Clinical, Molecular, and Neuroimaging Features vol.27, pp.6, 2017, https://doi.org/10.1097/rmr.0000000000000185